These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 24402955)

  • 1. ICR expands CanSAR drug discovery platform.
    Cancer Discov; 2014 Jan; 4(1):OF3. PubMed ID: 24402955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. canSAR: update to the cancer translational research and drug discovery knowledgebase.
    Coker EA; Mitsopoulos C; Tym JE; Komianou A; Kannas C; Di Micco P; Villasclaras Fernandez E; Ozer B; Antolin AA; Workman P; Al-Lazikani B
    Nucleic Acids Res; 2019 Jan; 47(D1):D917-D922. PubMed ID: 30496479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. canSAR: an updated cancer research and drug discovery knowledgebase.
    Tym JE; Mitsopoulos C; Coker EA; Razaz P; Schierz AC; Antolin AA; Al-Lazikani B
    Nucleic Acids Res; 2016 Jan; 44(D1):D938-43. PubMed ID: 26673713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. canSAR: update to the cancer translational research and drug discovery knowledgebase.
    Mitsopoulos C; Di Micco P; Fernandez EV; Dolciami D; Holt E; Mica IL; Coker EA; Tym JE; Campbell J; Che KH; Ozer B; Kannas C; Antolin AA; Workman P; Al-Lazikani B
    Nucleic Acids Res; 2021 Jan; 49(D1):D1074-D1082. PubMed ID: 33219674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. canSAR: update to the cancer translational research and drug discovery knowledgebase.
    di Micco P; Antolin AA; Mitsopoulos C; Villasclaras-Fernandez E; Sanfelice D; Dolciami D; Ramagiri P; Mica IL; Tym JE; Gingrich PW; Hu H; Workman P; Al-Lazikani B
    Nucleic Acids Res; 2023 Jan; 51(D1):D1212-D1219. PubMed ID: 36624665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. canSAR: updated cancer research and drug discovery knowledgebase.
    Bulusu KC; Tym JE; Coker EA; Schierz AC; Al-Lazikani B
    Nucleic Acids Res; 2014 Jan; 42(Database issue):D1040-7. PubMed ID: 24304894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The canSAR data hub for drug discovery.
    Chau CH; O'Keefe BR; Figg WD
    Lancet Oncol; 2016 Mar; 17(3):286. PubMed ID: 26972856
    [No Abstract]   [Full Text] [Related]  

  • 8. canSAR: an integrated cancer public translational research and drug discovery resource.
    Halling-Brown MD; Bulusu KC; Patel M; Tym JE; Al-Lazikani B
    Nucleic Acids Res; 2012 Jan; 40(Database issue):D947-56. PubMed ID: 22013161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphobase, an encyclopedic cell morphology database, and its use for drug target identification.
    Futamura Y; Kawatani M; Kazami S; Tanaka K; Muroi M; Shimizu T; Tomita K; Watanabe N; Osada H
    Chem Biol; 2012 Dec; 19(12):1620-30. PubMed ID: 23261605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. canSAR chemistry registration and standardization pipeline.
    Dolciami D; Villasclaras-Fernandez E; Kannas C; Meniconi M; Al-Lazikani B; Antolin AA
    J Cheminform; 2022 May; 14(1):28. PubMed ID: 35643512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical data mining of the NCI human tumor cell line database.
    Wang H; Klinginsmith J; Dong X; Lee AC; Guha R; Wu Y; Crippen GM; Wild DJ
    J Chem Inf Model; 2007; 47(6):2063-76. PubMed ID: 17915856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.
    Kong D; Yamori T
    Bioorg Med Chem; 2012 Mar; 20(6):1947-51. PubMed ID: 22336246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Q&A: Paul Workman on big data and large biases.
    Workman P
    Cancer Discov; 2013 Apr; 3(4):369. PubMed ID: 23580268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing cancer drug discovery towards more agile development of targeted combination therapies.
    Carragher NO; Unciti-Broceta A; Cameron DA
    Future Med Chem; 2012 Jan; 4(1):87-105. PubMed ID: 22168166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gene expression database for the molecular pharmacology of cancer.
    Scherf U; Ross DT; Waltham M; Smith LH; Lee JK; Tanabe L; Kohn KW; Reinhold WC; Myers TG; Andrews DT; Scudiero DA; Eisen MB; Sausville EA; Pommier Y; Botstein D; Brown PO; Weinstein JN
    Nat Genet; 2000 Mar; 24(3):236-44. PubMed ID: 10700175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current parallel chemistry principles and practice: application to the discovery of biologically active molecules.
    Edwards PJ
    Curr Opin Drug Discov Devel; 2009 Nov; 12(6):899-914. PubMed ID: 19894197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy.
    Zhang E; Zhang C; Su Y; Cheng T; Shi C
    Drug Discov Today; 2011 Feb; 16(3-4):140-6. PubMed ID: 21182981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of zebrafish embryos for small molecule screening related to cancer.
    Terriente J; Pujades C
    Dev Dyn; 2013 Feb; 242(2):97-107. PubMed ID: 23203901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The National Cancer Institute Experimental Therapeutics program.
    Doroshow JH
    Clin Adv Hematol Oncol; 2010 Jun; 8(6):403-4. PubMed ID: 20733549
    [No Abstract]   [Full Text] [Related]  

  • 20. Academia-industry alliance: Belfer Institute and sanofi-aventis collaborate to develop new cancer therapeutics.
    Dis Model Mech; 2010; 3(11-12):669. PubMed ID: 21030419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.